Pharmacological targets of breast cancer stem cells: a review

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Background:

• Breast cancers harbor a subpopulation of tumor-initiating cells known as breast cancer stem cells (BCSCs).
• BCSCs are resistant to conventional chemotherapy and are implicated in cancer metastasis, recurrence, and treatment failure.
• Understanding BCSCs' unique survival mechanisms is crucial for developing effective breast cancer therapies.

Purpose of the Study:

• To review the complex molecular mechanisms underlying breast cancer stem cell survival.
• To identify and discuss potential pharmacological targets for the elimination of BCSCs.

Main Methods:

• This review synthesizes current research on breast cancer stem cell biology.
• It examines various molecular pathways, including self-renewal, drug resistance, and microenvironment interactions.
• Key survival mechanisms and potential therapeutic targets are analyzed.

Main Results:

• BCSCs possess distinct molecular machinery enabling their survival and propagation.
• Identified targets include surface biomarkers, self-renewal proteins, drug efflux pumps, and metabolic pathways.
• Microenvironment interactions and apoptotic/antiapoptotic protein regulation are critical for BCSCs.

Conclusions:

• Targeting the unique molecular vulnerabilities of BCSCs is essential for overcoming therapeutic resistance and preventing cancer relapse.
• Pharmacological strategies aimed at BCSCs hold significant potential for improving breast cancer treatment efficacy.
• Further research into BCSCs' complex biology will pave the way for novel therapeutic interventions.